Onkar Sawant, B.Pharm, Ph.D has been with Eversight since June 2019 and oversees the organization’s research and innovations efforts, collaborating with academic and industry scientists to accelerate discoveries and advance clinical practices to prevent vision loss. Prior to joining Eversight, he completed a postdoctoral fellowship in ophthalmic research at the Cleveland Clinic Cole Eye Institute. Dr. Sawant holds a bachelor’s degree in pharmacy from Mumbai University, and a doctorate in biomedical sciences and a master’s degree in biotechnology business from Texas A&M University. In 2018, Dr. Sawant was named an Emerging Vision Scientist by the National Alliance for Eye and Vision Research. He has authored more than 25 peer-reviewed original research articles including high-impact publications in The FASEB Journal, The Ocular Surface Journal, Cornea and Cell Reports. He has extensive experience in the fields of ophthalmic research, pharmacology, toxicology and genetics.